UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis

The New England journal of medicine, 2014-10, Vol.371 (17), p.1577-1587

2014

Link zum Volltext

Verfügbarkeit prüfen

High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis

The New England journal of medicine, 2014-10, Vol.371 (17), p.1599-1608

2014

Link zum Volltext

Verfügbarkeit prüfen

An evaluation of culture results during treatment for tuberculosis as surrogate endpoints for treatment failure and relapse

PloS one, 2013-05, Vol.8 (5), p.e63840-e63840

2013

Link zum Volltext

Verfügbarkeit prüfen

Estimands for clinical endpoints in tuberculosis treatment randomized controlled trials: a retrospective application in a completed trial

Trials, 2024-03, Vol.25 (1), p.180-180

2024

Link zum Volltext

Verfügbarkeit prüfen

A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis

Nature medicine, 2018-11, Vol.24 (11), p.1708-1715

2018

Link zum Volltext

Verfügbarkeit prüfen

Principles for designing future regimens for multidrug-resistant tuberculosis

Bulletin of the World Health Organization, 2014-01, Vol.92 (1), p.68-74

2014

Link zum Volltext

Verfügbarkeit prüfen

The Impact of a Line Probe Assay Based Diagnostic Algorithm on Time to Treatment Initiation and Treatment Outcomes for Multidrug Resistant TB Patients in Arkhangelsk Region, Russia

PloS one, 2016-04, Vol.11 (4), p.e0152761-e0152761

2016

Link zum Volltext

Verfügbarkeit prüfen

Use of whole-genome sequencing to distinguish relapse from reinfection in a completed tuberculosis clinical trial

BMC medicine, 2017-03, Vol.15 (1), p.71-71, Article 71

2017

Link zum Volltext

Verfügbarkeit prüfen

Molecular Bacterial Load Assay, a Culture-Free Biomarker for Rapid and Accurate Quantification of Sputum Mycobacterium tuberculosis Bacillary Load during Treatment

Journal of Clinical Microbiology, 2011-11, Vol.49 (11), p.3905-3911

2011

Link zum Volltext

Verfügbarkeit prüfen

Tuberculosis screening improves preventive therapy uptake (TB SCRIPT) trial among people living with HIV in Uganda: a study protocol of an individual randomized controlled trial

Trials, 2022-05, Vol.23 (1), p.399-399, Article 399

2022

Link zum Volltext

Verfügbarkeit prüfen

A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis

The New England journal of medicine, 2019-03, Vol.380 (13), p.1201-1213

2019

Link zum Volltext

Verfügbarkeit prüfen

Protocol for the 3HP Options Trial: a hybrid type 3 implementation-effectiveness randomized trial of delivery strategies for short-course tuberculosis preventive therapy among people living with HIV in Uganda

Implementation science : IS, 2020-08, Vol.15 (1), p.65-65, Article 65

2020

Link zum Volltext

Verfügbarkeit prüfen

Precision-Enhancing Risk Stratification Tools for Selecting Optimal Treatment Durations in Tuberculosis Clinical Trials

American journal of respiratory and critical care medicine, 2021-11, Vol.204 (9), p.1086-1096

2021

Link zum Volltext

Verfügbarkeit prüfen

Setting Tuberculosis Regimen Development on a Firm Foundation

Clinical infectious diseases, 2017-07, Vol.65 (1), p.55-56

Phillips, Patrick P J

2017

Link zum Volltext

Verfügbarkeit prüfen

Toxicity associated with tuberculosis chemotherapy in the REMoxTB study

BMC infectious diseases, 2018-07, Vol.18 (1), p.317-11, Article 317

2018

Link zum Volltext

Verfügbarkeit prüfen

A comparison of liquid and solid culture for determining relapse and durable cure in phase III TB trials for new regimens

BMC medicine, 2017-11, Vol.15 (1), p.207-207, Article 207

2017

Link zum Volltext

Verfügbarkeit prüfen

Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape

PLoS medicine, 2019-03, Vol.16 (3), p.e1002767-e1002767

2019

Link zum Volltext

Verfügbarkeit prüfen

Protocol for a feasibility randomized controlled trial to evaluate the efficacy, safety and tolerability of N-acetylcysteine in reducing adverse drug reactions among adults treated for multidrug-resistant tuberculosis in Tanzania

Pilot and feasibility studies, 2023-04, Vol.9 (1), p.55-55, Article 55

2023

Link zum Volltext

Verfügbarkeit prüfen

Spot sputum samples are at least as good as early morning samples for identifying Mycobacterium tuberculosis

BMC medicine, 2017-10, Vol.15 (1), p.192-192, Article 192

2017

Link zum Volltext

Verfügbarkeit prüfen

Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status

BMC pulmonary medicine, 2019-08, Vol.19 (1), p.152-9, Article 152

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of Cotrimoxazole on Carriage and Antibiotic Resistance of Streptococcus pneumoniae and Haemophilus influenzae in HIV-Infected Children in Zambia

Antimicrobial Agents and Chemotherapy, 2010-09, Vol.54 (9), p.3756-3762

2010

Link zum Volltext

Verfügbarkeit prüfen

Mycobactericidal Effects of Different Regimens Measured by Molecular Bacterial Load Assay among People Treated for Multidrug-Resistant Tuberculosis in Tanzania

Journal of clinical microbiology, 2021-03, Vol.59 (4)

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 624

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(544)
Mit Volltextzugriff
(548)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis

High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis

An evaluation of culture results during treatment for tuberculosis as surrogate endpoints for treatment failure and relapse

Estimands for clinical endpoints in tuberculosis treatment randomized controlled trials: a retrospective application in a completed trial

Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial

A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis

Principles for designing future regimens for multidrug-resistant tuberculosis

The Impact of a Line Probe Assay Based Diagnostic Algorithm on Time to Treatment Initiation and Treatment Outcomes for Multidrug Resistant TB Patients in Arkhangelsk Region, Russia

Use of whole-genome sequencing to distinguish relapse from reinfection in a completed tuberculosis clinical trial

Molecular Bacterial Load Assay, a Culture-Free Biomarker for Rapid and Accurate Quantification of Sputum Mycobacterium tuberculosis Bacillary Load during Treatment

Tuberculosis screening improves preventive therapy uptake (TB SCRIPT) trial among people living with HIV in Uganda: a study protocol of an individual randomized controlled trial

A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis

Protocol for the 3HP Options Trial: a hybrid type 3 implementation-effectiveness randomized trial of delivery strategies for short-course tuberculosis preventive therapy among people living with HIV in Uganda

Precision-Enhancing Risk Stratification Tools for Selecting Optimal Treatment Durations in Tuberculosis Clinical Trials

Setting Tuberculosis Regimen Development on a Firm Foundation

Toxicity associated with tuberculosis chemotherapy in the REMoxTB study

A comparison of liquid and solid culture for determining relapse and durable cure in phase III TB trials for new regimens

An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial

Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape

Protocol for a feasibility randomized controlled trial to evaluate the efficacy, safety and tolerability of N-acetylcysteine in reducing adverse drug reactions among adults treated for multidrug-resistant tuberculosis in Tanzania

Spot sputum samples are at least as good as early morning samples for identifying Mycobacterium tuberculosis

Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses

Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status

Impact of Cotrimoxazole on Carriage and Antibiotic Resistance of Streptococcus pneumoniae and Haemophilus influenzae in HIV-Infected Children in Zambia

Mycobactericidal Effects of Different Regimens Measured by Molecular Bacterial Load Assay among People Treated for Multidrug-Resistant Tuberculosis in Tanzania

Suchergebnisse filtern